scholarly journals A Suspected Allergic Reaction to Boal Fish (Wallago Attu)

2020 ◽  
Vol 4 (9) ◽  
pp. CR1-CR4
Author(s):  
Ramesh Puri ◽  
Jayati Batra

Consumption of fish has increased around the globe due to its high nutritional value and this has led to an increase in incidence of allergic reactions to fish. Reactions to fish are not only mediated by the immune system causing allergies but are often caused by proteins, metals, various toxins and parasites. Allergic reactions to fish can range from being mild and self-limiting to serious and life threatening. We report a case of an adult with suspected allergic reaction to Boal fish (Wallago Attu) who developed contact dermatitis during marinating process. Application of steroids and administration of oral antihistaminic led to a quick recovery.

Author(s):  
Åslög Dahl ◽  
Matilda van den Bosch ◽  
Thomas Ogren

Allergic diseases are caused by hypersensitivity of the immune system to a certain environmental exposure. Many different agents may induce an allergic reaction. This chapter concerns reactions to pollen. Although allergies to animals, for example dogs and cats, may be considered as part of nature-induced allergy, the focus here is on vegetation. Allergic reactions to pollen depend on the type of pollen, biological properties, location, and individual factors. Changes in our immune systems, our living environments and lifestyles, and climate change may play a role in the increasing prevalence of pollen allergies. This chapter contains three major sections: first, the basics of pollen biology are outlined; secondly, pollen’s impact on human health are introduced; and finally, the chapter includes a section on how practitioners and policymakers can plan our cities to be green, and yet limited in allergenic exposure.


Author(s):  
Ludger Klimek ◽  
Natalija Novak ◽  
Eckard Hamelmann ◽  
Thomas Werfel ◽  
Martin Wagenmann ◽  
...  

SummaryTwo employees of the National Health Service (NHS) in England developed severe allergic reactions following administration of BNT162b2 vaccine against COVID-19 (coronavirus disease 2019). The British SmPC for the BNT162b2 vaccine already includes reference to a contraindication for use in individuals who have had an allergic reaction to the vaccine or any of its components. As a precautionary measure, the Medicines and Healthcare products Regulatory Agency (MHRA) has issued interim guidance to the NHS not to vaccinate in principle in “patients with severe allergies”. Allergic reactions to vaccines are very rare, but vaccine components are known to cause allergic reactions. BNT162b2 is a vaccine based on an mRNA embedded in lipid nanoparticles and blended with other substances to enable its transport into the cells. In the pivotal phase III clinical trial, the BNT162b2 vaccine was generally well tolerated, but this large clinical trial, used to support vaccine approval by the MHRA and US Food and Drug Administration, excluded individuals with a “history of a severe adverse reaction related to the vaccine and/or a severe allergic reaction (e.g., anaphylaxis) to a component of the study medication”. Vaccines are recognized as one of the most effective public health interventions. This repeated administration of a foreign protein (antigen) necessitates a careful allergological history before each application and diagnostic clarification and a risk–benefit assessment before each injection. Severe allergic reactions to vaccines are rare but can be life-threatening, and it is prudent to raise awareness of this hazard among vaccination teams and to take adequate precautions while more experience is gained with this new vaccine.


2018 ◽  
Vol 10 (2) ◽  
pp. 52-55
Author(s):  
Bisera Kotevska Trifunova ◽  
Zdravka V. Demerdjieva ◽  
Nikolay K. Tsankov ◽  
Jana S. Kazandjieva

Abstract Nowadays, allergic reactions in children are seen in dermatological practice on a daily basis. The most common reasons for allergic contact dermatitis (ACD) are piercings, temporary tattoos, a wide range of cosmetic products, substances related to the practice of a variety of hobbies and sports, etc. Slime is a new hobby and has become an obsession for some kids. There are many homemade slime recipes. The most common recipe for slime is glue, borax and food coloring for all kinds of rainbow effects. We present a case of an 11-year-old Caucasian girl with hand contact dermatitis caused by an allergic reaction to Slime.


2021 ◽  
Vol 18 (1) ◽  
pp. 73-78
Author(s):  
Marina A. Mokronosova ◽  
Tatiana M. Zheltikova

Tropomyosins are a family of allergenic proteins found in large quantities in all invertebrates. Tropomyosins sensitization causes a life-threatening allergic reaction up to anaphylaxis after eating seafood. Identifying the source of primary sensitization is important to predict the allergic reaction severity. This article describes a clinical case of chronic recurrent urticaria in an 8-year-old boy with tropomyosins sensitization. An 8-year-old boy was diagnosed with the following: controlled atopic phenotype bronchial asthma, food allergy (oral allergy syndrome), and chronic recurrent spontaneous urticaria. Component diagnostics revealed IgE-aB to tropomyosins in high concentrations from 38.79 to 43.38 kUA/l and cat and dog uteroglobin and lipocalins in high concentrations from 7.79 to 43.38 kUA/l. It is necessary to specify the primary sensitizer to analyze the clinical significance of allergens that provoke sensitization to various groups of allergens. In this case, sensitization to tropomyosins is most likely described as caused by either a helminthic invasion or midge bites. Therefore, food allergic reactions to tropomyosins caused from crustaceans were not observed.


2018 ◽  
Vol 104 (1) ◽  
pp. 83-90 ◽  
Author(s):  
Katherine Anagnostou ◽  
Paul J Turner

Anaphylaxis is a serious systemic allergic reaction that is rapid in onset and may cause death. Despite numerous national and international guidelines and consensus statements, common misconceptions still persist in terms of diagnosis and appropriate management, both among healthcare professionals and patient/carers. We address some of these misconceptions and highlight the optimal approach for patients who experience potentially life-threatening allergic reactions.


2019 ◽  
Vol 31 (4) ◽  
pp. 975-980
Author(s):  
Hristijan Spasov ◽  
Mire Spasov ◽  
Icko Gjorgoski ◽  
Majlinda Ademi

Allergic reactions in the body are initiated by non-pathogenic allergens that cause hypersensitivity to the immune system of the type I hypersensitivity group, characterized by excessive activation of the cells of the white blood cell, mast cells and basophils by IgE, resulting in an inflammatory response. The particles of the allergen in the body mainly penetrate the mucous membranes of the body openings causing a series of reactions by activating T cells and B cells. The main symptoms of allergic reactions are secretion from the mucous membrane, irritation, swelling with itching and redness. The aim of the research came from the assume that in the white laboratory rat, when treated with an allergen isolated from the pollen of the Phleum pratense plant, there may be an allergic reaction, and hence a change in some parameters of the immune system.As a result of these assumptions the following specific goals were set. To determine the change in the concentration of immunoglobulins in serum from the blood taken from the rats every week for a month, to determine the variation in the total number of leukocytes, determine the number of basophils that compared to the reference value will indicate whether there are certain changes. The basophils were the target of the study because it is known that their number is the same with the number of mast cells that also increase during the allergic reaction. Our goal was also to determine the changes in the above parameters in relation to the different concentration of the allergen.As an experimental model we used white laboratory rats from the Wistar kind.All of them were female at the age of 6 to 9 weeks. The chosen age is due to their genetic predisposition to develop Th2-type cells that are involved in the immune response to the model of the allergy that has been studied. The rats were divided into three groups of six animals, the first group of rats being treated with an allergen in a quantity of 5 μL, adsorbed in 100 μl Al (OH) 3 (Serva, Heidelburg, Germany, 2 mg / mL) in a total volume of 150 μl sterile PbS., treated with a recombinant allergen from Phleum pratense at room temperature, a second group treated with an allergen in an amount of 2.5 μl, and a third group of control rats that are not treated and serve to compare the results. Our studies have shown that in the treatment with an allergen isolated from the pollen of the plant Phleum pratense at concentrations of 5 μl and 2.5 μl,the white laboratory rat develops an allergic reaction with a change in the concentration of immunoglobulins, changes in the total number of leucocytes, the percentage of lymphocytes , monocytes and basophils. The results obtained by the ELISA test of the two volumes show that the concentrations of immunoglobulins during the experimental period of day by day, are continuously increasing, and are proportional to the volume of the allergen.


2020 ◽  
Vol 11 (4) ◽  
pp. 87-90
Author(s):  
Robin George Manappallil ◽  
Thushara Anand

Allergic reactions can be mild or life threatening. Food-dependent exercise-induced anaphylaxis (FDEIA) is a severe form of allergic reaction in which symptoms develop only after exercising within a few hours of eating a specific food. The condition is, at times, underdiagnosed. Proper history taking is essential, especially when patients present with allergic reactions after exertion and food intake. The patient being described developed FDEIA because of exercising after eating nuts. 


1970 ◽  
Vol 9 (2) ◽  
Author(s):  
Bertha Wong MD ◽  
Maria Bagovich MD ◽  
Ivan Blasutig PhD ◽  
Simon Carette MD MPhil

This article describes a patient presenting with a sensory polyneuropathy and multiple autoantibodies, leading to the diagnosis of hepatitis C virus (HCV) infection. His widely positive autoantibody profile in the absence of clinically significant rheumatic disease illustrates the importance of interpreting autoimmune serology in the appropriate clinical context and the concept of HCV being a non-specific activator of the immune system. In addition, it highlights the importance of considering untreated HCV infection in the differential diagnosis of rheumatic complaints, particularly if the workup reveals multiple autoantibodies, as HCV is a potentially severe and life-threatening disease, which can be appropriately managed with effective antiviral therapy.


Medicina ◽  
2021 ◽  
Vol 57 (8) ◽  
pp. 782
Author(s):  
Entaz Bahar ◽  
Hyonok Yoon

The most widely used medications in dentistry are local anesthetics (LA), especially lidocaine, and the number of recorded adverse allergic responses, particularly of hazardous responses, is quite low. However, allergic reactions can range from moderate to life-threatening, requiring rapid diagnosis and treatment. This article serves as a review to provide information on LA, their adverse reactions, causes, and management.


Blood ◽  
2012 ◽  
Vol 119 (22) ◽  
pp. 5111-5117 ◽  
Author(s):  
Aida Inbal ◽  
Johannes Oldenburg ◽  
Manuel Carcao ◽  
Anders Rosholm ◽  
Ramin Tehranchi ◽  
...  

Congenital factor XIII (FXIII) deficiency is a rare, autosomal-recessive disorder, with most patients having an A-subunit (FXIII-A) deficiency. Patients experience life-threatening bleeds, impaired wound healing, and spontaneous abortions. In many countries, only plasma or cryoprecipitate treatments are available, but these carry a risk for allergic reactions and infection with blood-borne pathogens. The present study was a multinational, open-label, single-arm, phase 3 prophylaxis trial evaluating the efficacy and safety of a novel recombinant FXIII (rFXIII) in congenital FXIII-A subunit deficiency. Forty-one patients ≥ 6 years of age (mean, 26.4; range, 7-60) with congenital FXIII-A subunit deficiency were enrolled. Throughout the rFXIII prophylaxis, only 5 bleeding episodes (all trauma induced) in 4 patients were treated with FXIII-containing products. The crude mean bleeding rate was significantly lower than the historic bleeding rate (0.138 vs 2.91 bleeds/patient/year, respectively) for on-demand treatment. Transient, non-neutralizing, low-titer anti-rFXIII Abs developed in 4 patients, none of whom experienced allergic reactions, any bleeds requiring treatment, or changes in FXIII pharmacokinetics during the trial or follow-up. These non-neutralizing Abs declined below detection limits in all 4 patients despite further exposure to rFXIII or other FXIII-containing products. We conclude that rFXIII is safe and effective in preventing bleeding episodes in patients with congenital FXIII-A subunit deficiency. This study is registered at http://www..clinicaltrials.gov as number NCT00713648.


Sign in / Sign up

Export Citation Format

Share Document